The European artificial tear market is growing at a significant CAGR of 4.6% during the forecast period. The market is growing due to various factors such as the increasing prevalence of dry eye syndrome. Artificial tears are used to lubricate dry eyes and moisturize the outer surface of the eyes. It is also used to treat dry eyes caused due to surgery, certain medical conditions, medications aging, and smoky or windy conditions, among others. The incidence and prevalence of dry eye are rising among the population, especially in developed nations of Europe. Dry eye is caused by multiple factors that result in discomfort, irritation, and visual disturbance. For instance, in April 2020, according to a study ‘National Health and Wellness Survey’ conducted in Germany, ~7.4 million people were diagnosed with dry eye. The data also stated that the prevalence has gone up by 2.7% among people of age 18?34 years. Additionally, the prevalence was 18.6% among older people. Based on sex, the percentage of prevalence was higher in women; it accounted for 8.8% than men with 4.5%.
However, various factors are restraining the market growth including side effects caused by artificial tears resulting in eye pain, red eyes, irritation, among others. Although, innovations such as preservative-free artificial tears in artificial tears could be perceived as a major opportunity for the players engaged in the market.
The European artificial tears market is segmented based on type, application, and delivery method. Based on type, the market is segmented into cellulose-derived tears, glycerin-derived tears, oil-based emulsion tears, polyethylene glycol- & propylene glycol-based tears. Based on application, the market is fragmented into dry type treatment, contact lens moisture, others. Based on the delivery method, the market is bifurcated into eye drops and, ointments.
Geographically, the market is classified into the UK, Germany, France, Spain, Italy, and the Rest of Europe. While, the key companies included in the report of the European artificial tear market are Abbott Medical Optics Inc., Akorn, Inc., Alcon Laboratories, Inc., Allergan, Inc., Bausch and Lomb, Johnson & Johnson, Novartis International AG, Ocusoft Inc., Rohto Pharmaceutical Co., Ltd, Santen Pharmaceutical Co. Ltd, Similasan Corp., URSAPHARM Arzeinmittel GmbH, WUHAN Yuanda, among more. The companies operating in the artificial tears market are constantly focusing on product launches covering a wide range of users, R&Ds, partnerships, M&As, and technological advancements. The report also includes a detailed market overview, strategic recommendations, key company analysis, key findings, analyst insights, predictive analysis, pipeline analysis, market determinants, market segmentation, geographical analysis, and company profiling of the market.
Research Methodology
The market study of the European artificial tear market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. COVID-19 Impact on Market
2.3. Analyst Insight & Current Market Trends
2.3.1. Key Findings
2.3.2. Recommendations
2.3.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. European Artificial Tears Market by Type
5.1.1. Cellulose-Derived Tears
5.1.2. Glycerin-Derived Tears
5.1.3. Oil-Based Emulsion Tears
5.1.4. Polyethylene Glycol- & Propylene Glycol-Based Tears
5.2. European Artificial Tears Market by Application
5.2.1. Dry Type Treatment
5.2.2. Contact Lens Moisture
5.3. European Artificial Tears Market Delivery Method
5.3.1. Eyedrops
5.3.2. Ointments
6. Regional Analysis
6.1. Europe
6.1.1. UK
6.1.2. Germany
6.1.3. Italy
6.1.4. Spain
6.1.5. France
6.1.6. Rest of Europe
7. Company Profiles
7.1. Abbott Medical Optics, Inc.
7.2. Akorn, Inc.
7.3. Alcon, Inc.
7.4. Allergan, PLC
7.5. Bausch And Lomb, Inc.
7.6. Carl Zeiss Meditec AG
7.7. Johnson And Johnson Service, Inc.
7.8. Nicox S.A.
7.9. Novagali Pharma S.A.
7.10. Novamedica LLC
7.11. Novartis International AG
7.12. Novaliq GMBH
7.13. Ocusoft Inc.
7.14. Shire PLC
7.15. Similasan Corp.
7.16. Sylentis S.A.
7.17. Ursapharm Arzneimittel GmbH
7.18. Ziemer Ophthalmic System AG
1. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
2. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2020-2027 ($ MILLION)
3. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY DELIVERY METHOD, 2020-2027 ($ MILLION)
4. EUROPEAN ARTIFICIAL TEARS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
1. EUROPEAN ARTIFICIAL TEARS MARKET SHARE BY TYPE, 2020 VS 2027 (%)
2. EUROPEAN ARTIFICIAL TEARS MARKET SHARE BY APPLICATION, 2020 VS 2027 (%)
3. EUROPEAN ARTIFICIAL TEARS MARKET SHARE BY DELIVERY METHOD, 2020 VS 2027 (%)
4. EUROPEAN ARTIFICIAL TEARS MARKET SHARE BY COUNTRY, 2020 VS 2027 (%)
5. UK ARTIFICIAL TEARS MARKET SIZE, 2020-2027 ($ MILLION)
6. GERMANY ARTIFICIAL TEARS MARKET SIZE, 2020-2027 ($ MILLION)
7. FRANCE ARTIFICIAL TEARS MARKET SIZE, 2020-2027 ($ MILLION)
8. SPAIN ARTIFICIAL TEARS MARKET SIZE, 2020-2027 ($ MILLION)
9. ITALY ARTIFICIAL TEARS MARKET SIZE, 2020-2027 ($ MILLION)
10. REST OF EUROPEAN ARTIFICIAL TEARS MARKET SIZE, 2020-2027 ($ MILLION)